阿托伐他汀钙中间体的合成

张立光,於学良*,吴芝园,丁荣敏,俞学炜

主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
中国医药工业杂志 ›› 2013, Vol. 44 ›› Issue (10) : 975-977.
化学药物与合成技术 Chemical Drug & Synthetic Technology

阿托伐他汀钙中间体的合成

作者信息 +

Synthesis of the Intermediate of Atorvastatin Calcium

Author information +
History +

摘要

(3S)-4- 溴-3- 羟基丁酸乙酯经缩合、不对称生物催化还原及羟基保护制得[(4R,6S)-6- 溴甲基-2,2- 二甲基-1,3- 二氧杂环己烷-4- 基] 乙酸叔丁酯( 5),5 在溴化亚铜及含氮化合物配体作用下与硝基甲烷缩合后,经雷尼镍催化氢化还原制得阿托伐他汀钙中间体[(4R,6R)-6-(2- 氨基乙基)-2,2- 二甲基-1,3- 二氧杂环己烷-4- 基] 乙酸叔丁酯,总收率约41%。

Abstract

tert-Butyl [(4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate, the intermediate of atorvastatin calcium, was synthesized from (3S)-ethyl-4-bromo-3-hydroxybutanoat by condensation, asymmetric biocatalytic reduction and hydroxyl protection to give tert-butyl [(4R,6S)-6-bromomethyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate, which was subjected to condensation with CH3NO2 in the presence of CuBr/ligand, followed by reduction with an overall yield of about 41%.

关键词

[(4R / 6R)-6-(2-氨基乙基)-2 / 2-二甲基-1 / 3-二氧杂环己烷-4-基]乙酸叔丁酯 / 阿托伐他汀钙 / 降血脂药 / 中间体 / 合成

Key words

tert-butyl [(4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate / atorvastatin calcium / hypolipidemic drug / intermediate / synthesis

引用本文

导出引用
张立光,於学良*,吴芝园,丁荣敏,俞学炜. 阿托伐他汀钙中间体的合成. 中国医药工业杂志. 2013, 44(10): 975-977
ZHANG Liguang, YU Xueliang*, WU Zhiyuan, DING Rongmin, YU Xuewei. Synthesis of the Intermediate of Atorvastatin Calcium. Chinese Journal of Pharmaceuticals. 2013, 44(10): 975-977

参考文献

[1] 叶 健, 刘 玥, 李朝亮. 阿托伐他汀钙的制备方法: 中国, 101613312 [P]. 2009-12-30.

[2] Wess G, Kesseler K, Baader E, et al. Stereoselective synthesis of HR 780 a new highly potent HMG-CoA reductase inhibitor [J]. Tetrahedron Lett, 1990, 31(18): 2545-2548.

[3] Lee I, Lee S. New process for the preparation of optically active of optically active 2-[6-(substituted alkyl) -1,3-dioxan-4-yl]acetic acid derivatives: WO, 03053950 [P]. 2003-07-03.

[4] Beck G, Jendralla JH, Kesseler K. Process for preparing tert-butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate: US, 5399722 [P]. 1995-03-21.

[5] Kizaki NM, Yamada Y. Process for the preparation of optically active 2-[(6-hydroxymethyl)-1,3-dioxan-4-yl]-acetic acid derivatives: US, 6472544 [P]. 2002-10-29.

[6] 张宪恕. 两种含1,4- 双羟基结构脂肪酸的首次不对称全合成, 降血脂药物阿托伐他汀钙的新工艺研发[D]. 兰州: 兰州大学, 2008: 55-87.

[7] Thottathil JK, Pendri Y. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMGCoA reductase inhibitors: US, 5278313 [P]. 1994-01-11.

[8] Gildner PG, Gietter AA, Cui D, et al. Benzylation of nitroalkanes using copper-catalyzed thermal redox catalysis: toward the facile C-alkylation of nitroalkanes [J]. J Am

Chem Soc, 2012, 134(24): 9942-9945.

[9] 熊绪杰, 熊进军, 何年兵. 阿伐他汀中间体(3R,5S)-7- 氨基-3,5-O- 异丙叉-3,5- 二羟基庚酸叔丁酯的制备方法: 中国, 102391243 [P]. 2011-10-17.

[10] Rádl S. A new way to tert-butyl (4R,6R)-6-aminoethyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate, a key intermediate of atorvastatin synthesis [J]. Synth Commun, 2003, 33(13):

2275-2283.

基金

苏州市科技发展计划项目(STSD2011072)

155

Accesses

0

Citation

Detail

段落导航
相关文章

/